Pathological hypertrophy amelioration by PRAS40-mediated inhibition of mTORC1
Mirko Völkers(German Cancer Research Center), Mark A. Sussman(San Diego State University), Haruhiro Toko(Max Planck Institute of Biochemistry), Anya Joyo(San Diego State University), Pearl Quijada(Broad Center), Christopher C. Glembotski(San Diego State University), Mathias H. Konstandin(Heidelberg University), Eri Joyo(San Diego State University), Shirin Doroudgar(University of Phoenix), Natalie Gude(San Diego State University), Donna J. Thuerauf(Baylor College of Medicine), Luis Ornelas(San Diego State University), Shabana Din(San Diego State University)
Cited by 104
Related Papers
p38 MAPK and NF-κB Collaborate to Induce Interleukin-6 Gene Expression and Release
|Journal of Biological Chemistry|2000|338
Endoplasmic Reticulum Stress Gene Induction and Protection From Ischemia/Reperfusion Injury in the Hearts of Transgenic Mice With a Tamoxifen-Regulated Form of ATF6
|Circulation Research|2006|315
Myocardial AKT: The Omnipresent Nexus
|Physiological Reviews|2011|222
Cardiac adenoviral S100A1 gene delivery rescues failing myocardium
|Journal of Clinical Investigation|2004|209
Atrial natriuretic peptide promotes cardiomyocyte survival by cGMP-dependent nuclear accumulation of zyxin and Akt
|Journal of Clinical Investigation|2005|159